Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: The role of glycogen-synthase-kinase-3β

Neuroscience

Volumn 152, Issue 3, 2008, Pages 656-669

  Silva, R ^a   Mesquita, A R ^a   Bessa, J ^a   Sousa, J C ^a   Sotiropoulos, I ^b   Leao P ^a   Almeida, O F X ^b   Sousa, N ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

B cell CLL lymphoma 2; Bcl2 associated athanogene; chronic mild stress; glycogen synthase kinase 3 ; plasticity; synapsin I

Indexed keywords

AR A 014418; BAG 1 PROTEIN; BROXURIDINE; CORTICOSTERONE; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; SYNAPSIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE RELEASE; DEPRESSION; DRUG BLOOD LEVEL; DRUG MECHANISM; FORCED SWIMMING TEST; HIPPOCAMPUS; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RAT; SUBVENTRICULAR ZONE;

ADRENAL GLANDS; ANIMALS; ANTIMANIC AGENTS; BEHAVIOR, ANIMAL; BODY WEIGHT; CELL PROLIFERATION; CELL SURVIVAL; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; LITHIUM CHLORIDE; MALE; NEURONAL PLASTICITY; NEURONS; RATS; RATS, WISTAR; STEM CELLS; STRESS, PSYCHOLOGICAL; SYNAPSINS; SYNAPTIC TRANSMISSION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 40949125640     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.12.026     Document Type: Article

References (64)

1. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., and Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 14 (2000) 779-790
2. Altman J., and Das G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124 (1965) 319-335
3. Axelson D.A., Doraiswamy P.M., McDonald W.M., Boyko O.B., Tupler L.A., Patterson L.J., Nemeroff C.B., Ellinwood Jr. E.H., and Krishnan K.R. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 47 (1993) 163-173
4. Bhat R., Xue Y., Berg S., Hellberg S., Ormo M., Nilsson Y., Radesater A.C., Jerning E., Markgren P.O., Borgegard T., Nylof M., Gimenez-Cassina A., Hernandez F., Lucas J.J., Diaz-Nido J., and Avila J. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418. J Biol Chem 278 (2003) 45937-45945
5. Bijur G.N., De Sarno P., and Jope R.S. Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem 275 (2000) 7583-7590
6. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., and Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 157 (2000) 115-118
7. Cerqueira J.J., Catania C., Sotiropoulos I., Schubert M., Kalisch R., Almeida O.F., et al. Corticosteroid status influences the volume of the rat cingulate cortex: a magnetic resonance imaging study. J Psychiatr Res 39 (2005) 451-460
8. Chen G., Rajkowska G., Du F., Seraji-Bozorgzad N., and Manji H.K. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 75 (2000) 1729-1734
9. Chen R.W., and Chuang D.M. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274 (1999) 6039-6042
10. Chuang D.M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., and Leeds P. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 4 (2002) 129-136
11. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F., and Almeida O.F. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10 (2005) 790-798
12. Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., and Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci U S A 98 (2001) 12796-12801
13. Czeh B., Welt T., Fischer A.K., Erhardt A., Schmitt W., Muller M.B., Toschi N., Fuchs E., and Keck M.E. Chronic psychosocial stress and concomitant repetitive transcranial magnetic stimulation: effects on stress hormone levels and adult hippocampal neurogenesis. Biol Psychiatry 52 (2002) 1057-1065
14. D'Sa C., and Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord 4 (2002) 183-194
15. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat Med 4 (1998) 1313-1317
16. Forbes E.E., and Dahl R.E. Neural systems of positive affect: relevance to understanding child and adolescent depression?. Dev Psychopathol 17 (2005) 827-850
17. Fuchs E., Czeh B., Kole M.H., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14 Suppl 5 (2004) S481-S490
18. Fukumoto T., Morinobu S., Okamoto Y., Kagaya A., and Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 158 (2001) 100-106
19. Gould E., Woolley C.S., Cameron H.A., Daniels D.C., and McEwen B.S. Adrenal steroids regulate postnatal development of the rat dentate gyrus: II. Effects of glucocorticoids and mineralocorticoids on cell birth. J Comp Neurol 313 (1991) 486-493
20. Gould E., Woolley C.S., and McEwen B.S. Adrenal steroids regulate postnatal development of the rat dentate gyrus: I. Effects of glucocorticoids on cell death. J Comp Neurol 313 (1991) 479-485
21. Gould T.D., Einat H., Bhat R., and Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. Int J Neuropsychopharmacol 7 (2004) 387-390
22. Gould T.D., Picchini A.M., Einat H., and Manji H.K. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Curr Drug Targets 7 (2006) 1399-1409
23. Gundersen H.J., and Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147 Pt 3 (1987) 229-263
24. Hall A.C., Brennan A., Goold R.G., Cleverley K., Lucas F.R., Gordon-Weeks P.R., and Salinas P.C. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons. Mol Cell Neurosci 20 (2002) 257-270
25. Hall A.C., Lucas F.R., and Salinas P.C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100 (2000) 525-535
26. Heine V.M., Maslam S., Joels M., and Lucassen P.J. Prominent decline of newborn cell proliferation, differentiation, and apoptosis in the aging dentate gyrus, in absence of an age-related hypothalamus-pituitary-adrenal axis activation. Neurobiol Aging 25 (2004) 361-375
27. Heine V.M., Maslam S., Zareno J., Joels M., and Lucassen P.J. Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur J Neurosci 19 (2004) 131-144
28. Jope R.S. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24 (2003) 441-443
29. Lee Y., Gaskins D., Anand A., and Shekhar A. Glia mechanisms in mood regulation: a novel model of mood disorders. Psychopharmacology (Berl) 191 (2007) 55-65
30. Lucassen P.J., Fuchs E., and Czeh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55 (2004) 789-796
31. Lucassen P.J., Vollmann-Honsdorf G.K., Gleisberg M., Czeh B., De Kloet E.R., and Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur J Neurosci 14 (2001) 161-166
32. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
33. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat Med 7 (2001) 541-547
34. Manji H.K., Moore G.J., and Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry 61 Suppl 9 (2000) 82-96
35. Manji H.K., Moore G.J., Rajkowska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5 (2000) 578-593
36. Mayer J.L., Klumpers L., Maslam S., de Kloet E.R., Joels M., and Lucassen P.J. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis. J Neuroendocrinol 18 (2006) 629-631
37. Mervaala E., Fohr J., Kononen M., Valkonen-Korhonen M., Vainio P., Partanen K., et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 30 (2000) 117-125
38. Moser M.B., and Moser E.I. Functional differentiation in the hippocampus. Hippocampus 8 (1998) 608-619
39. Phiel C.J., and Klein P.S. Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 41 (2001) 789-813
40. Price L.H., Charney D.S., Delgado P.L., and Heninger G.R. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology (Berl) 100 (1990) 3-12
41. Redrobe J.P., and Bourin M. The effect of lithium administration in animal models of depression: a short review. Fundam Clin Pharmacol 13 (1999) 293-299
42. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., and Lesch K.P. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11 (2006) 514-522
43. Rosenbrock H., Koros E., Bloching A., Podhorna J., and Borsini F. Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats. Brain Res 1040 (2005) 55-63
44. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
45. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
46. Schneikert J., Hubner S., Martin E., and Cato A.C. A nuclear action of the eukaryotic cochaperone RAP46 in downregulation of glucocorticoid receptor activity. J Cell Biol 146 (1999) 929-940
47. Semba J., Watanabe H., Suhara T., and Akanuma N. Chronic lithium chloride injection increases glucocorticoid receptor but not mineralocorticoid receptor mRNA expression in rat brain. Neurosci Res 38 (2000) 313-319
48. Silva R., Lu J., Wu Y., Martins L., Almeida O.F., and Sousa N. Mapping cellular gains and losses in the postnatal dentate gyrus: Implications for psychiatric disorders. Exp Neurol 200 (2006) 321-331
49. Song L., Zhou T., and Jope R.S. Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 5 (2004) 20
50. Sotiropoulos I., Catania C., Silva R., Sousa N., and Almeida O.F.X. Glucocorticoids and stress influence on Alzheimer's disease-like pathology: a novel mechanism linking glucocorticoid receptor activation to cognitive impairment. Alzheimers Dementia 2 Suppl 1 (2006) S470
51. Sousa N., and Almeida O.F. Corticosteroids: sculptors of the hippocampal formation. Rev Neurosci 13 (2002) 59-84
52. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., and Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 97 (2000) 253-266
53. Sousa N., Madeira M.D., and Paula-Barbosa M.M. Corticosterone replacement restores normal morphological features to the hippocampal dendrites, axons and synapses of adrenalectomized rats. J Neurocytol 28 (1999) 541-558
54. Stambolic V., Ruel L., and Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6 (1996) 1664-1668
55. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J.A., and Reed J.C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80 (1995) 279-284
56. Tomasiewicz H.C., Mague S.D., Cohen B.M., and Carlezon Jr. W.A. Behavioral effects of short-term administration of lithium and valproic acid in rats. Brain Res 1093 (2006) 83-94
57. Vasconcellos A.P., Tabajara A.S., Ferrari C., Rocha E., and Dalmaz C. Effect of chronic stress on spatial memory in rats is attenuated by lithium treatment. Physiol Behav 79 (2003) 143-149
58. Vitiello B., Zuvekas S.H., and Norquist G.S. National estimates of antidepressant medication use among U.S. children, 1997-2002. J Am Acad Child Adolesc Psychiatry 45 (2006) 271-279
59. Vollmayr B., Simonis C., Weber S., Gass P., and Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54 (2003) 1035-1040
60. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005) 90-110
61. Wong H., Anderson W.D., Cheng T., and Riabowol K.T. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal Biochem 223 (1994) 251-258
62. Wood G.E., Young L.T., Reagan L.P., Chen B., and McEwen B.S. Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci U S A 101 (2004) 3973-3978
63. Xu H., He J., Richardson J.S., and Li X.M. The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine. J Neurochem 91 (2004) 1380-1388
64. Zhou R., Gray N.A., Yuan P., Li X., Chen J., Chen G., Damschroder-Williams P., Du J., Zhang L., and Manji H.K. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J Neurosci 25 (2005) 4493-4502